RPTX

Repare Therapeutics Inc. RPTX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RPTX ALXO BMEA ACRV IMUX PMVP DTIL UNCY CAMP ATYR
6M 45.58 % 188.84 % -40.25 % 110.83 % -22.79 % 14.35 % 2.24 % -8.52 % 320.78 % -85.19 %
YTD 62.12 % -5.13 % -61.79 % -55.54 % -39.07 % -19.28 % 6.82 % -21.34 % 31.44 % -80.30 %
1Y 33.75 % -3.90 % -75.90 % -63.86 % -44.01 % -20.83 % 5.70 % -11.00 % 1.89 % -74.58 %
3Y -85.60 % -86.81 % -80.74 % -79.78 % -50.67 % -87.28 % -86.42 % -11.63 % -39.55 % -55.48 %
5Y -94.58 % -98.15 % -91.71 % -84.80 % -96.69 % -97.27 % -97.92 % -87.54 % -39.55 % -55.48 %
10Y -93.05 % -95.07 % -91.71 % -84.80 % -99.85 % -96.71 % -99.04 % -87.54 % -39.55 % -55.48 %
From the beginning -93.05 % -95.07 % -91.71 % -84.80 % -99.87 % -96.71 % -99.04 % -87.54 % -39.55 % -55.48 %

Dividend